BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10743092)

  • 1. [Interleukin-6 and tumor necrosis factor-alpha in middle ear effusions].
    Xie M; Zhou L; Jin X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):280-2. PubMed ID: 10743092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nitric oxide and cytokines in otitis media with effusion].
    Lin G; Huang W; Jiang H; Wang J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 35(1):23-5. PubMed ID: 12768683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Superoxide dismutase and cytokines in otitis media with effusion].
    Dong W; Li Z; Zhou S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):452-4. PubMed ID: 12541690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cytokines present in middle ear effusions.
    Yellon RF; Leonard G; Marucha PT; Craven R; Carpenter RJ; Lehmann WB; Burleson JA; Kreutzer DL
    Laryngoscope; 1991 Feb; 101(2):165-9. PubMed ID: 1992267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 expression in otitis media.
    Maxwell KS; Fitzgerald JE; Burleson JA; Leonard G; Carpenter R; Kreutzer DL
    Laryngoscope; 1994 Aug; 104(8 Pt 1):989-95. PubMed ID: 8052085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection.
    Nell MJ; Grote JJ
    Laryngoscope; 1999 Nov; 109(11):1815-9. PubMed ID: 10569413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
    Närkiö-Mäkelä M; Teppo AM; Meri S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of otitis media with effusion based on the ratio of albumin and immunoglobulin G concentrations in the effusion.
    Rezes S; Késmárki K; Sipka S; Sziklai I
    Otol Neurotol; 2007 Aug; 28(5):663-7. PubMed ID: 17667774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines in experimental otitis media with effusion.
    Johnson MD; Fitzgerald JE; Leonard G; Burleson JA; Kreutzer DL
    Laryngoscope; 1994 Feb; 104(2):191-6. PubMed ID: 8302123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
    Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD
    Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media.
    Russo E; Smith CW; Friedman EM; Smith EO; Kaplan SL
    Otolaryngol Head Neck Surg; 2004 Feb; 130(2):242-8. PubMed ID: 14990922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytokine levels in bilateral ear effusions in patients with otitis media secretoria.
    Matkovic S; Vojvodic D; Baljosevic I
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):450-3. PubMed ID: 17765774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory and immunoregulatory cytokines in the middle ear effusions.
    Skotnicka B; Hassmann E
    Int J Pediatr Otorhinolaryngol; 2008 Jan; 72(1):13-7. PubMed ID: 17976828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of mucin secretion in HT29-MTX cells by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-6.
    Smirnova MG; Kiselev SL; Birchall JP; Pearson JP
    Eur Cytokine Netw; 2001 Mar; 12(1):119-25. PubMed ID: 11282555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
    Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
    Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
    Zhang W; Yue B; Wang GQ; Lu SL
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of endotoxin to tumor necrosis factor-alpha and interleukin-1 beta in children with otitis media with effusion.
    Willett DN; Rezaee RP; Billy JM; Tighe MB; DeMaria TF
    Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):28-33. PubMed ID: 9439385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.